Market Cap | 12.91M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -3.59M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 3.00% |
Sales | 571.68k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -43.00% | |
Recommedations | - | Quick Ratio | 0.22 | Shares Outstanding | 1.86B | 52W Low Chg | 53.00% |
Insider Own | - | ROA | - | Shares Float | - | Beta | 1.11 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00490 |
Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 753,622 | Target Price | - |
Oper. Margin | -845.23% | Earnings Date | Nov 18 | Volume | 1,878,200 | Change | 3.16% |
LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.